AOD9604
Original price was: $64.00.$52.00Current price is: $52.00.
Recommended product: Acetic Acid
In stock
Become a Member and save 20% on Every Order.
Description
AOD9604
AOD9604 peptide Details
AOD9604 Certificate of Analysis
Third-party tested. Click image to view full-resolution certificate.
AOD9604 is a synthetic peptide derived from the C-terminal fragment (176–191) of human growth hormone (hGH), modified to enhance stability and preserve specific metabolic properties while minimizing broader growth hormone–related effects. In research models, AOD9604 has been investigated primarily for its role in lipid metabolism, where it has been shown to influence lipolysis (fat breakdown) and lipogenesis (fat storage).
As a research-only compound, AOD9604 is used to explore mechanisms of adipose tissue regulation, cartilage and joint biology, and cardiometabolic pathways in preclinical settings. It is not approved for human or veterinary consumption and is supplied strictly for controlled laboratory use.
About AOD9604 peptide
AOD9604 is a modified hGH fragment containing a di-sulfide bridge that enhances its structural stability. Unlike full-length hGH, AOD9604 is designed to selectively mimic the lipolytic region of the hormone without significantly impacting growth-promoting pathways. This makes it a useful tool for researchers studying:
- Regulation of adipose tissue metabolism
- Energy balance and obesity-related pathways
- Joint and cartilage biology in osteoarthritis models
- Metabolic factors associated with cardiovascular and systemic syndromes
In animal studies, AOD9604 has been reported to stimulate lipolysis and inhibit lipogenesis under specific experimental conditions, providing a platform to dissect signaling mechanisms involved in fat turnover and metabolic control.
AOD9604 peptide Scientific Research
1. AOD9604 and Obesity Models
AOD9604 was originally developed as an hGH analogue with targeted activity against excess adipose tissue. Preclinical and early-phase clinical investigations have examined its impact on body weight and fat mass:
- In obese animal models, AOD9604 has been associated with reductions in body weight and fat mass over defined treatment periods.
- Research indicates that AOD9604 can promote fat loss even in models lacking functional β3-adrenergic receptors, suggesting that additional mechanisms beyond classical adrenergic signaling are involved.
- These findings have led to hypotheses that AOD9604 may influence apoptosis pathways in white adipose tissue or engage other fat-specific signaling cascades.
In a human research context, AOD9604 has been evaluated in controlled settings to observe its impact on weight-related endpoints and the sustainability of these effects over several weeks. The data are interpreted as mechanistic insights rather than as evidence of established therapeutic efficacy.
2. AOD9604, Joint Function, and Cartilage Research
Beyond adipose-focused studies, AOD9604 has been examined in experimental models of joint disease and osteoarthritis:
- In rat models, intra-articular administration of AOD9604 has been explored for its effects on pain-related behavior, joint function, and structural parameters.
- Some studies have reported improvements in gross clinical assessment and microscopic cartilage features when AOD9604 is combined with existing interventions.
- These observations suggest that AOD9604 may interact with cartilage metabolism and joint remodeling pathways, making it a candidate tool for investigating chondrocyte activity, matrix turnover, and osteoarthritic progression in preclinical models.
The mechanisms underlying these potential synergistic effects remain under active investigation and may involve growth factor signaling, extracellular matrix synthesis, or anti-catabolic pathways in joint tissues.
3. AOD9604 and Cardiometabolic Research
Because excess adiposity is closely linked to cardiovascular risk, AOD9604 has also been studied in the broader context of cardiometabolic health:
- Fat reduction alone can influence cardiovascular biomarkers, but some studies suggest that AOD9604 may have effects on metabolic parameters that are not solely explained by weight loss.
- Researchers are exploring whether secondary pathways engaged by AOD9604—particularly those independent of β3-adrenergic receptor activation—may modulate lipid profiles, inflammatory markers, or other risk factors in animal models.
- Comparisons have been drawn to other agents that improve metabolic status without directly causing weight loss, supporting continued interest in AOD9604 as a mechanistic research tool.
These investigations aim to clarify how specific hGH-derived fragments can selectively impact metabolic networks and cardiovascular-related endpoints.
AOD9604 peptide FAQ
Q1: What is AOD9604?
A1: AOD9604 is a synthetic peptide derived from the human growth hormone fragment 176–191, modified to enhance stability and selectively support research on lipid metabolism and related pathways.
Q2: What are the primary research applications of AOD9604?
A2: Researchers use AOD9604 to study adipose tissue metabolism, obesity models, joint and cartilage biology, and cardiometabolic pathways in preclinical systems.
Q3: How does AOD9604 differ from full-length human growth hormone?
A3: Unlike full-length hGH, AOD9604 is designed to focus on lipolytic and anti-lipogenic activity while minimizing broader growth-related effects, making it more targeted for metabolic research applications.
Q4: Is AOD9604 intended for human or veterinary use?
A4: No. AOD9604 is supplied strictly for laboratory research use and is not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any condition.
Q5: What has animal research suggested about AOD9604’s bioavailability?
A5: Studies in animal models have reported favorable oral and subcutaneous bioavailability for AOD9604; however, these findings do not translate directly to humans and are used only to guide preclinical experimental design.
Storage & Handling
All peptides are supplied as sterile, lyophilized powder and are stable when handled correctly.- On arrival: Store vials in a cool, dry place away from heat and direct sunlight.
- Long-term (powder): For optimal longevity, keep lyophilized peptides refrigerated to help maintain integrity.
- After reconstitution: Use an appropriate research diluent (for example, BAC water). Store the reconstituted solution in the refrigerator and use within 20–30 days for best stability.
Note: Minimize exposure to moisture and repeated freeze–thaw cycles. Follow your institution's safety procedures when handling research materials.
Storage & Handling
All peptides are supplied as sterile, lyophilized powder and are stable when handled correctly.
- On arrival: Store vials in a cool, dry place away from heat and direct sunlight.
- Long-term (powder): For optimal longevity, keep lyophilized peptides refrigerated to help maintain integrity.
- After reconstitution: Use an appropriate research diluent (for example, BAC water). Store the reconstituted solution in the refrigerator and use within 20–30 days for best stability.
Note: Minimize exposure to moisture and repeated freeze–thaw cycles. Follow your institution's safety procedures when handling research materials.
Peak Lab Peptides maintains quality-control processes and routinely performs third-party testing to support purity and identity verification. COAs are available upon request for applicable batches. Documentation may vary depending on production timelines.
We aim to make batch-level documentation available whenever possible. Our goal is to expand COA access across the full catalog as production capacity grows.
All products are for laboratory research use only and are not intended for human consumption.
Related Products
GLP-1 Tirz
Tirzepatide
GLP-1 Tirz – 5mg (Lyophilized Peptide) – For Research Use Only
GLP-1 Tirz is a research-grade GLP-1 receptor agonist analog studied for its potential impact on appetite regulation, glucose control, insulin sensitivity, and metabolic health. GLP-1 T is part of a class of peptides evaluated for their role in weight management, satiety signaling, and glycemic balance in metabolic research models.
KLOW Blend 80mg – GHK-Cu, TB-500, BPC-157, KPV
KLOW Blend
KLOW – 80mg Peptide Blend (Lyophilized Powder) – For Research Use Only GHK-Cu • TB-500 • BPC-157 • KPV
KLOW is an advanced 4-in-1 research peptide blend combining 80mg of compounds studied for their potential in tissue repair signaling, immune modulation, and cellular recovery mechanisms in controlled laboratory environments. Each component contributes a distinct and complementary mechanism of action, making KLOW a subject of interest in multi-pathway research models.
Active Ingredients (Per Vial):
GHK-Cu – 50mg A copper-binding tripeptide studied for its role in collagen synthesis, cellular regeneration signaling, and extracellular matrix remodeling in laboratory research models.
TB-500 – 10mg A synthetic fragment of Thymosin Beta-4 studied for its interaction with G-actin sequestration, angiogenesis pathway activity, and cell migration mechanisms in preclinical research.
BPC-157 – 10mg A synthetic pentadecapeptide derived from a gastric protein, studied for its role in tissue repair signaling, NO system modulation, and VEGF pathway activity in controlled research environments.
KPV – 10mg A naturally occurring tripeptide fragment studied for its role in inflammatory signaling pathway modulation and immune regulation mechanisms across multiple tissue types.
Product Details:
- Total Peptide Content: 80mg per vial
- Form: Lyophilized powder
- Purity: >99%
- Quantity: 80mg vial
- Storage: Store at -4°F (-20°C). After reconstitution, refrigerate at 36–46°F (2–8°C) and use within 30 days.
- Grade: For research purposes only. Not for human consumption, therapeutic, or diagnostic use.
Potential Research Applications:
- Multi-peptide synergy and complementary pathway mechanism studies
- Cellular regeneration signaling and extracellular matrix research
- Inflammatory pathway modulation and immune regulation models
- Angiogenesis, cell migration, and tissue repair signaling investigations
For laboratory research only. This product is not intended to diagnose, treat, cure, or prevent any disease.
Lipo-C (w/ B12 & w/o B12)
Lipo-C
Lipo-C – 10ml Sterile Injectable Solution – For Research Use Only
Lipo-C is a research-grade lipotropic formulation studied for its potential effects on fat metabolism, energy production, and liver function. This blend combines amino acids, vitamins, and metabolic cofactors designed to support laboratory studies involving lipid transport, metabolic regulation, and cellular energy pathways.
Active Ingredients (Per ml):
-
L-Carnitine – 200mg
-
Arginine – 20mg
-
Methionine – 25mg
-
Inositol – 50mg
-
Choline – 50mg
-
Vitamin B5 (Dexpanthenol) – 25mg
-
Vitamin B6 (Pyridoxine) – 25mg
-
Vitamin B12 (Cyanocobalamin) – 1mg
Product Details:
-
Volume: 10ml multi-dose vial
-
Formulation: Sterile injectable solution
-
Purity: Research grade
-
Storage: Store at 68–77°F (20–25°C)
- Product will crystalize slightly if refrigerated.
-
Grade: For laboratory research use only. Not for human consumption, therapeutic, or diagnostic use.
Potential Research Applications:
-
Lipid metabolism and fat mobilization studies
-
Liver function and detoxification research
-
Energy production and mitochondrial pathway exploration
-
Metabolic health and nutrient utilization investigations
For laboratory research only. This product is not intended to diagnose, treat, cure, or prevent any disease.